Gene therapy has sparked the interest of medical professionals worldwide since it was first developed, and now is being researched as a potential treatment for genetic disorders that previously are with limited access to treatment approaches. Genetic hearing loss, one of the most common genetic disorders, is found to be linked to pathogenic variants in over 150 genes, and gene therapy presents great potential in curing this disease.
To share the latest advance in gene therapy development and promote industry-academia communication, Creative Biolabs has launched a webinar program and is honored to invite Dr. Jeffrey R. Holt this time to talk about his work in the upcoming free webinar. Dr. Jeffrey is a Professor and Director of Research in the Department of Otolaryngology at Boston Children’s Hospital and Harvard Medical School, and his lab is focused on gene therapy for genetic hearing loss using gene replacement, gene editing and base editing.
“We have an active research group focused on the function, dysfunction and restoration of the auditory system,” as introduced by Dr. Jeffrey, “we want to understand why genetic mutations cause hearing loss and vestibular dysfunction. We are using this information to design novel therapeutic innervations to treat deafness and balance disorders.”
In this live webinar, Dr. Jeffrey will explain his latest work on how gene therapy has become a promising treatment for genetic hearing loss and how his team developed unique gene therapy strategies for genetic hearing loss. All webinar attendees will be able to ask further questions during the live Q&A following the presentation.
Topic: Development of Gene Therapy for Genetic Hearing Loss
Time/Date: 3:00 PM EDT, July 21, 2022
Speaker: Dr. Jeffrey R. Holt
Key discussion points include:
- Hearing loss affects ~400 million people worldwide but there is no biological treatment available
- Gene therapy for genetic hearing loss is a promising treatment modality
- The development of gene therapy to treat two forms of genetic hearing loss
Creative Biolabs understand that for most researchers, finding the time to stay up to date with the latest research can be challenging, so an email notification will be sent to every registrant when it becomes available to watch on demand for free.
About Creative Biolabs
With years of experience in providing one-stop preclinical development services, Creative Biolabs has built a team of experts with solid knowledge of gene therapy, and is fully competent in providing services for worldwide clients. The services include but are not limited to delivery vehicle development, gene editing, RNAi therapy development, safety and toxicology analysis, potency tests, and solutions of specific gene therapy development for diseases.
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Boston New Times journalist was involved in the writing and production of this article.